Proscia Concentriq AP(-Dx)
Proscia Concentriq Clinical Products
At Proscia, we’re rewiring pathology for precision medicine. Concentriq® is our cloud-native enterprise platform for research and clinical digital pathology. It provides a unified workflow, high-performance image viewing, and integration with LIS, scanners, and AI applications. Concentriq® AP is for research-use only and fuels anatomic pathology research and AI evaluation, while Concentriq AP-Dx is FDA 510(k)-cleared and CE-marked for primary diagnosis.
Proscia was named Global 2026 Best in KLAS for Digital Pathology (Europe), with 100% of surveyed customers indicating they would buy again. Concentriq is on track to power 8+ million diagnoses annually and is trusted by over 12,000 pathologists and scientists at laboratories of all sizes.
Digital Pathology Transformation with Concentriq
Concentriq replaces manual, fragmented pathology workflows with a fully digital, enterprise-ready platform. From slide ingestion to case sign-out, Concentriq standardizes processes, streamlines review workflows, and enables consistent diagnostic quality.
- Digital case assembly and multi-site worklist management
- Standardized review environment with high-fidelity, low-latency rendering
- Automated QC, AI-assisted case review, and quantitative tools
- Scalable storage and ingestion pipelines for high-volume labs
- Interoperability with LIS, scanners, and clinical systems
Built with Pathologists, for Pathologists
Concentriq’s browser-based viewer delivers high-resolution images with low-latency rendering and microscope-like navigation. Shared worklists, case assignments, and structured tooling support distributed teams and consistent review across sites.
- Instant streaming of WSI at 40x
- Annotations, measurements, side-by-side review
- Shared worklists and case routing for multi-site operations
- Role-based access and centralized case storage


Interoperable Systems Empowering Care
Concentriq is an open platform that supports major scanners, WSI formats, and LIS systems. With the Proscia Ready partner ecosystem and API-based integrations, labs can incorporate AI applications, data pipelines, and enterprise infrastructure without disruption.
- Supports major WSI formats*
- LIS integration via HL7, FHIR, and vendor APIs
- Cloud-native deployment on AWS/Azure/GCP**
- Proscia Ready ecosystem for validated AI and workflow tools***
*Not all image formats are intended for diagnostic use; see instructions for use for limitations.
**Cloud deployment is unavailable in certain regions.
***These applications are not intended for diagnostic use with Concentriq. Contact original manufacturers for details about indications for use in your region. Applications included in the suites are powered by Proscia and select third-party developers, including IBEX, OWKIN, and Visiopharm. All solutions are seamlessly interoperable with Concentriq and delivered with unified support by Proscia.

Precision Medicine AI Workflows*
Concentriq integrates AI into routine pathology workflow, enabling slide QC, image analysis, and quantitative scoring within the primary review interface. The platform supports model orchestration, versioning, and standardized output formats.
- Automated QC for slide and image integrity with >96% accuracy**
- AI applications supporting cancer detection, grading, and biomarker analysis
- Expanding portfolio of research and diagnostic AI across tissue types

*These applications are not intended for diagnostic use with Concentriq. Contact original manufacturers for details about indications for use in your region. Applications included in the suites are powered by Proscia and select third-party developers, including IBEX, OWKIN, and Visiopharm. All solutions are seamlessly interoperable with Concentriq and delivered with unified support by Proscia.
**AutoQC is for use in Concentriq AP. Concentriq AP is for Research Use Only. Not for use in diagnostic procedures.
Join our Global Laboratory Network
Proscia Aperture transforms everyday diagnostic work at clinical labs into a strategic gateway for precision medicine — enabling labs to become full partners in research, trial enrollment, and real-world data generation.
- Turn routine diagnoses into real-time insights
- Enable automated cohorting for trial matching
- Unlock access to a globally diverse diagnostic dataset
- Minimal workflow impact—no additional data preparation required
Enterprise-Grade Security and Compliance
Concentriq is built to operate in highly regulated environments, providing encryption, audit logging, access controls, and SSO to support secure, compliant digital pathology workflows. All deployments meet HIPAA and GDPR requirements, and Concentriq AP-Dx is FDA 510(k)-cleared and CE-marked for primary diagnosis.
- 12,000+ global pathologists and scientists trust Concentriq
- 8M+ patients set to be diagnosed in Concentriq in 2025 (32k+ daily)
- High trust software – ISO 27001 certified, SOC 2 Type II attested, and more — Concentriq meets the highest global standards

Your Partner in Digital Pathology: Empowering Success at Every Step
Proscia’s CX, Professional Services, and Technical Support teams support deployment, workflow integration, and operational scaling of Concentriq environments.
- Deployment and go-live in days with guided configuration
- Defined SLAs and enterprise-grade support
- Ongoing adoption support for new features and integrations
More Solutions from Proscia
Compare Solutions
Get Pathology News Delivered to Your Inbox
Learn More
Proscia News
Proscia Receives New FDA 510(k) Clearance for Concentriq AP-Dx with Predetermined Change Control Plan
Editor2026-08-06T18:10:26+00:00August 6, 2026|
How We Built Intelligence into the Pathology Platform
Editor2026-07-24T14:44:58+00:00July 20, 2026|
Proscia Launches Fifth Generation of Concentriq, Bringing the Latest Advancements in AI to Pathologists and Scientists
Editor2026-06-23T15:32:27+00:00June 17, 2026|
NextGen Pathology Selects Proscia to Establish AI Foundation for Business Growth
Editor2026-06-11T16:01:23+00:00June 3, 2026|
Reflections on KLAS’ US Digital Pathology Report: What it Means to Be a Long-Term Partner
Editor2026-05-15T14:41:12+00:00May 12, 2026|
Proscia Wins 2026 MedTech Breakthrough Award for Turning the Moment of Diagnosis into Drug Development Insights
Editor2026-05-13T11:19:48+00:00May 8, 2026|
From Glass Slide to Molecular Proxy: The Pathology AI Convergence at AACR 2026
Editor2026-05-12T12:58:29+00:00May 7, 2026|











